Literature DB >> 17557775

UK Consensus Conference on Early Chronic Kidney Disease--6 and 7 February 2007.

G Archibald1, W Bartlett, A Brown, B Christie, A Elliott, K Griffith, S Pound, I Rappaport, D Robertson, Y Semple, P Slane, C Whitworth, B Williams.   

Abstract

Entities:  

Mesh：

Year:  2007        PMID： 17557775     DOI： 10.1093/ndt/gfm268

Source DB:  PubMed          Journal:  Nephrol Dial Transplant        ISSN： 0931-0509            Impact factor:   5.992


× No keyword cloud information.
  13 in total

1.  The third World Kidney Day: looking back and thinking forward.

Authors:  Sudhir V Shah; John Feehally
Journal:  Pediatr Nephrol       Date:  2007-12-14       Impact factor: 3.714

2.  Timing of onset of CKD-related metabolic complications.

Authors:  Olivier Moranne; Marc Froissart; Jerome Rossert; Cedric Gauci; Jean-Jacques Boffa; Jean Philippe Haymann; Mona Ben M'rad; Christian Jacquot; Pascal Houillier; Benedicte Stengel; Bruno Fouqueray
Journal:  J Am Soc Nephrol       Date:  2008-11-12       Impact factor: 10.121

3.  Validation of The Health Improvement Network (THIN) database for epidemiologic studies of chronic kidney disease.

Authors:  Michelle R Denburg; Kevin Haynes; Justine Shults; James D Lewis; Mary B Leonard
Journal:  Pharmacoepidemiol Drug Saf       Date:  2011-08-24       Impact factor: 2.890

4.  Longitudinal association of depressive symptoms with rapid kidney function decline and adverse clinical renal disease outcomes.

Authors:  Willem J Kop; Stephen L Seliger; Jeffrey C Fink; Ronit Katz; Michelle C Odden; Linda F Fried; Dena E Rifkin; Mark J Sarnak; John S Gottdiener
Journal:  Clin J Am Soc Nephrol       Date:  2011-03-10       Impact factor: 8.237

5.  Fibroblast growth factor-23 is associated with C-reactive protein, serum phosphate and bone mineral density in chronic kidney disease.

Authors:  P Manghat; W D Fraser; A S Wierzbicki; I Fogelman; D J Goldsmith; G Hampson
Journal:  Osteoporos Int       Date:  2009-12-09       Impact factor: 4.507

6.  Longitudinal changes in kidney function following heart transplantation: Stanford experience.

Authors:  Adetokunbo A Taiwo; Kiran K Khush; Margaret R Stedman; Yuanchao Zheng; Jane C Tan
Journal:  Clin Transplant       Date:  2018-10-25       Impact factor: 2.863

7.  Hypokalemia and outcomes in patients with chronic heart failure and chronic kidney disease: findings from propensity-matched studies.

Authors:  C Barrett Bowling; Bertram Pitt; Mustafa I Ahmed; Inmaculada B Aban; Paul W Sanders; Marjan Mujib; Ruth C Campbell; Thomas E Love; Wilbert S Aronow; Richard M Allman; George L Bakris; Ali Ahmed
Journal:  Circ Heart Fail       Date:  2010-01-26       Impact factor: 8.790

8.  Urinary N-acetyl-β-D glucosaminidase as a surrogate marker for renal function in autosomal dominant polycystic kidney disease: 1 year prospective cohort study.

Authors:  Hayne Cho Park; Jin Ho Hwang; Ah-Young Kang; Han Ro; Myung-Gyu Kim; Jung Nam An; Ji In Park; Seung Hyup Kim; Jaeseok Yang; Yun Kyu Oh; Kook-Hwan Oh; Jung Woo Noh; Hae Il Cheong; Young-Hwan Hwang; Curie Ahn
Journal:  BMC Nephrol       Date:  2012-08-30       Impact factor: 2.388

9.  Increased urinary Angiotensinogen/Creatinine (AGT/Cr) ratio may be associated with reduced renal function in autosomal dominant polycystic kidney disease patients.

Authors:  Hayne Cho Park; Ah-Young Kang; Joon Young Jang; Hyunsuk Kim; Miyeun Han; Kook-Hwan Oh; Seung Hyup Kim; Jung Woo Noh; Hae Il Cheong; Young-Hwan Hwang; Curie Ahn
Journal:  BMC Nephrol       Date:  2015-06-20       Impact factor: 2.388

10.  Risk of moderate to advanced kidney disease in patients with psoriasis: population based cohort study.

Authors:  Joy Wan; Shuwei Wang; Kevin Haynes; Michelle R Denburg; Daniel B Shin; Joel M Gelfand
Journal:  BMJ       Date:  2013-10-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.